drugset / Trial / NCT02151994
Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to to assess the safety and tolerability of BIA 5 1058 after single and multiple oral doses
Timeline
- Start
- 2011-03
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIA 5-1058 | Unknown | 5 mg | Oral |
| Subject | BIA 5-1058 | Unknown | 25 mg | Oral |
| Subject | BIA 5-1058 | Unknown | 50 mg | Oral |
| Subject | BIA 5-1058 | Unknown | 100 mg | Oral |
| Subject | BIA 5-1058 | Unknown | 400 mg | Oral |